Hubei Biocause Pharmaceutical (000627) — Defensive Interval Ratio
Hubei Biocause Pharmaceutical (000627) has a Defensive Interval Ratio of 49 days as of September 2024. Defensive assets of CN¥2.34 Billion (cash CN¥-, short-term investments CN¥2.24 Billion, receivables CN¥98.56 Million) cover 49 days of daily cash needs of CN¥47.80 Million/day. Check Hubei Biocause Pharmaceutical (000627) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Hubei Biocause Pharmaceutical Defensive Interval Ratio (2000–2023)
This chart shows how Hubei Biocause Pharmaceutical's Defensive Interval Ratio has evolved across 24 annual periods from 2000 to 2023. As of September 2024, the ratio stands at 49 days, meaning defensive assets of CN¥2.34 Billion can fund 49 days of operations without new revenue. Also explore 000627 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Hubei Biocause Pharmaceutical (2000–2023)
The table below presents the year-by-year Defensive Interval Ratio for Hubei Biocause Pharmaceutical from 2000 to 2023, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 000627 company net worth.
| Year | DIR (days) | Defensive Assets (CNY) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 28 days | CN¥1.88 Billion | CN¥67.02 Million/day | CN¥- | CN¥1.80 Billion | ▼ -4 days |
| 2022 | 32 days | CN¥2.17 Billion | CN¥68.45 Million/day | CN¥- | CN¥2.08 Billion | ▼ -150 days |
| 2021 | 181 days | CN¥6.48 Billion | CN¥35.78 Million/day | CN¥- | CN¥2.91 Billion | ▲ +18 days |
| 2020 | 163 days | CN¥3.58 Billion | CN¥21.96 Million/day | CN¥- | CN¥3.56 Billion | ▲ +2 days |
| 2019 | 161 days | CN¥3.72 Billion | CN¥23.11 Million/day | CN¥- | CN¥2.21 Billion | ▲ +51 days |
| 2018 | 110 days | CN¥7.95 Billion | CN¥72.57 Million/day | CN¥- | CN¥- | ▼ -306 days |
| 2017 | 416 days | CN¥11.71 Billion | CN¥28.18 Million/day | CN¥- | CN¥4.16 Billion | ▼ -245 days |
| 2016 | 660 days | CN¥6.89 Billion | CN¥10.44 Million/day | CN¥- | CN¥- | ▲ +599 days |
| 2015 | 61 days | CN¥69.62 Million | CN¥1.14 Million/day | CN¥- | CN¥- | ▲ +1 days |
| 2014 | 60 days | CN¥94.65 Million | CN¥1.58 Million/day | CN¥- | CN¥- | ▲ +16 days |
| 2013 | 44 days | CN¥85.38 Million | CN¥1.93 Million/day | CN¥- | CN¥- | ▼ -81 days |
| 2012 | 125 days | CN¥168.99 Million | CN¥1.35 Million/day | CN¥- | CN¥- | ▼ -17 days |
| 2011 | 142 days | CN¥130.75 Million | CN¥917.73K/day | CN¥- | CN¥- | ▼ -14 days |
| 2010 | 156 days | CN¥102.46 Million | CN¥656.85K/day | CN¥- | CN¥- | ▲ +55 days |
| 2009 | 101 days | CN¥98.30 Million | CN¥976.13K/day | CN¥- | CN¥- | ▼ -16 days |
| 2008 | 117 days | CN¥98.38 Million | CN¥839.90K/day | CN¥- | CN¥16.08 Million | ▼ -7 days |
| 2007 | 124 days | CN¥145.52 Million | CN¥1.17 Million/day | CN¥- | CN¥3.22 Million | ▼ -28 days |
| 2006 | 152 days | CN¥172.70 Million | CN¥1.13 Million/day | CN¥- | CN¥1.34 Million | ▼ -61 days |
| 2005 | 213 days | CN¥208.33 Million | CN¥977.25K/day | CN¥- | CN¥- | ▲ +27 days |
| 2004 | 187 days | CN¥182.67 Million | CN¥979.20K/day | CN¥- | CN¥- | ▼ -65 days |
| 2003 | 252 days | CN¥256.93 Million | CN¥1.02 Million/day | CN¥- | CN¥- | ▼ -17 days |
| 2002 | 268 days | CN¥237.11 Million | CN¥883.25K/day | CN¥- | CN¥1.36 Million | ▲ +16 days |
| 2001 | 253 days | CN¥156.56 Million | CN¥619.44K/day | CN¥- | CN¥- | ▲ +30 days |
| 2000 | 223 days | CN¥172.70 Million | CN¥774.82K/day | CN¥- | CN¥- | — |